机器人内视镜设备市场 - 按产品类型（诊断、治疗）、应用（大肠镜检查、支气管镜检查、腹腔镜检查、胃镜检查）、最终用途（医院、门诊手术中心） - 全球预测，2024 - 2032

受人口老龄化人口增长和导致慢性病增加的生活方式因素变化的推动，全球机器人内视镜设备行业在 2024 年至 2032 年期间将以 11% 的复合年增长率增长。

据世界卫生组织称，非传染性疾病（NCD）每年夺走 4,100 万人的生命，占全球死亡人数的 74%。随着全球人口老化和生活方式的演变，糖尿病、心血管疾病、癌症和呼吸系统疾病等慢性病的发生率持续上升。这种人口结构的变化意味着对有效管理这些疾病的创新疗法、疗法和预防措施的需求增加。

因此，医疗保健产业的研发投资正在激增，导致针对特定慢性疾病的新型药物、医疗设备和数位健康解决方案的发现。此外，人们越来越重视旨在减少与慢性病相关的风险因素的预防性医疗保健计划、健康计划和生活方式干预措施。此外，远距医疗、穿戴式装置和健康监测应用程式等技术突破正在彻底改变患者护理，并使个人能够积极管理自己的健康。

机器人内视镜设备市场根据产品类型、应用、最终用途和地区进行分类。

诊断机器人内视镜设备细分市场将在 2032 年大幅成长，因为它们能够提供高清成像、精确的组织采样和内臟的即时视觉化。这些设备有助于早期发现和准确诊断各种胃肠道和呼吸系统疾病，包括溃疡、息肉、肿瘤和发炎性肠道疾病，从而诱导节段生长。

由于支气管镜检查广泛用于诊断和治疗肺癌、慢性阻塞性肺病 (COPD) 和肺纤维化等呼吸系统疾病，到 2032 年，支气管镜检查领域的机器人内视镜设备市场份额将获得成长。机器人支气管镜使临床医生能够以增强的可操作性和灵活性来导航复杂的气道解剖结构，从而促进精确的病灶定位、活检采集和治疗干预，从而推动肺段扩张。

在医疗保健基础设施快速扩张以及医疗技术投资不断增加的推动下，亚太地区机器人内视镜设备产业预计到 2032 年将大幅成长。此外，中国、印度和日本等国家呼吸系统疾病的盛行率不断上升，推动了机器人内视镜设备用于诊断和治疗目的的采用。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 胃肠道疾病和其他慢性疾病的发生率上升
    • 微创手术的需求不断增加
    • 肥胖和糖尿病盛行率上升，人口老化加剧
    • 内视镜技术的进步
  • 产业陷阱与挑战
    • 发展中国家缺乏熟练的医生和内视镜医师
• 成长潜力分析
• 监管环境
• 技术景观
• 波特的分析
• PESTEL分析
• 未来市场趋势

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品类型，2018 年 - 2032 年

• 主要趋势
• 诊断
• 治疗性

第 6 章：市场估计与预测：按应用划分，2018 年 - 2032 年

• 主要趋势
• 大肠镜检查
• 支气管镜检查
• 腹腔镜检查
• 胃镜
• 其他应用

第 7 章：市场估计与预测：按最终用途，2018 - 2032 年

• 主要趋势
• 医院
• 门诊手术中心
• 其他最终用户

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• AKTORmed GmbH
• Asensus Surgical Inc.
• Boston Scientific Corporation
• Brainlab AG
• CONMED Corporation
• FUJIFILM Holdings Corporation
• Intuitive Surgical, Inc.
• Karl Storz SE & Co. KG
• Medtronic plc
• Olympus Corporation
• Renishaw plc
• Richard Wolf GmbH

Global Robotic Endoscopy Devices Industry will grow at 11% CAGR during 2024-2032, driven by the growing aging population demographics and changing lifestyle factors contributing to the rise in chronic conditions.

According to WHO, Noncommunicable diseases (NCDs) claim the lives of 41 million people annually, accounting for 74% of global deaths. As global populations age and lifestyles evolve, the incidence of chronic conditions such as diabetes, cardiovascular diseases, cancer, and respiratory ailments continues to rise. This demographic shift translates into heightened demand for innovative treatments, therapies, and preventive measures to manage these conditions effectively.

Consequently, the healthcare sector is experiencing a surge in R&D investments, leading to the discovery of novel drugs, medical devices, and digital health solutions tailored to address specific chronic diseases. Additionally, there is a growing emphasis on preventive healthcare initiatives, wellness programs, and lifestyle interventions aimed at reducing the risk factors associated with chronic illnesses. Moreover, technological breakthroughs, such as telemedicine, wearable devices, and health monitoring apps, are revolutionizing patient care and empowering individuals to actively manage their health.

The Robotic Endoscopy Devices Market is classified based on product type, application, end-use, and region.

The diagnostic robotic endoscopy devices segment will grow appreciably through 2032, owing to their ability to provide high-definition imaging, precise tissue sampling, and real-time visualization of internal organs. These devices help in the early detection and accurate diagnosis of various gastrointestinal and respiratory conditions, including ulcers, polyps, tumors, and inflammatory bowel diseases, thereby inducing segment growth.

The Robotic Endoscopy Devices Market share from the bronchoscopy segment will gain traction by 2032 due to the widespread use of bronchoscopy in diagnosing and treating respiratory disorders such as lung cancer, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. Robotic bronchoscopy enables clinicians to navigate the intricate airway anatomy with enhanced maneuverability and dexterity, thus facilitating precise lesion localization, biopsy collection, and therapeutic interventions, thereby propelling segment expansion.

Asia Pacific Robotic Endoscopy Devices Industry is poised for substantial growth by 2032, driven by a rapidly expanding healthcare infrastructure, in line with increasing investments in medical technology. Additionally, the rising prevalence of respiratory diseases in countries such as China, India, and Japan is boosting the adoption of robotic endoscopy devices for both diagnostic and therapeutic purposes.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidences of gastrointestinal disorders and other chronic ailments
    • 3.2.1.2 Increasing demand for minimally invasive procedures
    • 3.2.1.3 Rise in prevalence of obesity and diabetes coupled with growing ageing population
    • 3.2.1.4 Technological advancements in endoscopy
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Dearth of skilled physicians and endoscopists in developing countries
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis
• 3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Diagnostic
• 5.3 Therapeutic

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Colonoscopy
• 6.3 Bronchoscopy
• 6.4 Laparoscopy
• 6.5 Gastroscopy
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 AKTORmed GmbH
• 9.2 Asensus Surgical Inc.
• 9.3 Boston Scientific Corporation
• 9.4 Brainlab AG
• 9.5 CONMED Corporation
• 9.6 FUJIFILM Holdings Corporation
• 9.7 Intuitive Surgical, Inc.
• 9.8 Karl Storz SE & Co. KG
• 9.9 Medtronic plc
• 9.10 Olympus Corporation
• 9.11 Renishaw plc
• 9.12 Richard Wolf GmbH